Teva Pharmaceutical Industries Limited (TLV:TEVA)
13,330
-590 (-4.24%)
Nov 19, 2026, 5:27 PM IST
TLV:TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.40B USD in the quarter ending September 30, 2026, a decrease of -1.90%. This brings the company's total for the last twelve months to $17.23B, up 2.71% year-over-year. In the year 2025, Teva Pharmaceutical Industries had annual revenue of $17.26B with 4.32% growth.
Revenue (ttm)
$17.23B
Revenue Growth
+2.71%
P/S Ratio
3.01
Revenue / Employee
$524.63K
Employees
32,842
Market Cap
154.91B ILS
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full TLV:TEVA breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 17.26B | 714.00M | 4.32% |
| Dec 31, 2024 | 16.54B | 698.00M | 4.40% |
| Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
| Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
| Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
| Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
| Dec 31, 2019 | 16.89B | -1.97B | -10.43% |
| Dec 31, 2018 | 18.85B | -3.00B | -13.72% |
| Dec 31, 2017 | 21.85B | -50.00M | -0.23% |
| Dec 31, 2016 | 21.90B | 2.25B | 11.45% |
| Dec 31, 2015 | 19.65B | -620.00M | -3.06% |
| Dec 31, 2014 | 20.27B | -42.00M | -0.21% |
| Dec 31, 2013 | 20.31B | -3.00M | -0.01% |
| Dec 31, 2012 | 20.32B | 2.01B | 10.95% |
| Dec 31, 2011 | 18.31B | 2.19B | 13.59% |
| Dec 31, 2010 | 16.12B | 2.22B | 15.99% |
| Dec 31, 2009 | 13.90B | 2.81B | 25.39% |
| Dec 31, 2008 | 11.09B | 1.68B | 17.83% |
| Dec 31, 2007 | 9.41B | 1.00B | 11.89% |
| Dec 31, 2006 | 8.41B | 3.16B | 60.15% |
| Dec 31, 2005 | 5.25B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 885.35M |
| Kamada | 603.87M |
| Rafa Laboratories | 459.86M |
| SofWave Medical | 310.85M |
| BrainsWay | 180.82M |
Teva Pharmaceutical Industries News
- 11 hours ago - Teva price target raised to $50 from $47 at Barclays - TheFly
- 23 hours ago - Teva chief medical officer Eric Hughes to leave company - TheFly
- 23 hours ago - Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company - GlobeNewsWire
- 2 days ago - Teva price target raised to $50 from $42 at Argus - TheFly
- 3 days ago - Teva announces FDA approval of Igalmi sublingual film for at-home use - TheFly
- 7 days ago - Teva price target raised to $56 from $44 at Piper Sandler - TheFly
- 8 days ago - Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030 - GlobeNewsWire
- 9 days ago - Alvotech initiated with a Buy at Jefferies - TheFly